High Growth Tech In China Featuring Beijing Wantai Biological Pharmacy Enterprise And Two Other Dynamic Stocks - Yahoo Finance
603392 Stock | 76.02 0.63 0.82% |
About 61% of Beijing Wantai's investor base is looking to short. The analysis of the overall investor sentiment regarding Beijing Wantai Biological suggests that many traders are alarmed. The current market sentiment, together with Beijing Wantai's historical and current headlines, can help investors time the market. In addition, many technical investors use Beijing Wantai Biological stock news signals to limit their universe of possible portfolio assets.
Beijing |
High Growth Tech In China Featuring Beijing Wantai Biological Pharmacy Enterprise And Two Other Dynamic Stocks Yahoo Finance
Read at news.google.com
Beijing Wantai Fundamental Analysis
We analyze Beijing Wantai's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beijing Wantai using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beijing Wantai based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Beijing Wantai is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Beijing Wantai Biological Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Beijing Wantai stock to make a market-neutral strategy. Peer analysis of Beijing Wantai could also be used in its relative valuation, which is a method of valuing Beijing Wantai by comparing valuation metrics with similar companies.
Peers
Beijing Wantai Related Equities
688109 | Hangzhou Pinming | 1.82 | ||||
688119 | Sinosteel Luonai | 0.92 | ||||
002304 | Jiangsu Yanghe | 0.23 | ||||
301397 | Chongqing Sulian | 0.24 | ||||
002065 | Dhc Software | 0.25 | ||||
002410 | Glodon Software | 0.53 | ||||
600449 | Ningxia Building | 0.80 | ||||
301131 | Super Dragon | 1.44 |
Complementary Tools for Beijing Stock analysis
When running Beijing Wantai's price analysis, check to measure Beijing Wantai's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beijing Wantai is operating at the current time. Most of Beijing Wantai's value examination focuses on studying past and present price action to predict the probability of Beijing Wantai's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beijing Wantai's price. Additionally, you may evaluate how the addition of Beijing Wantai to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |